Gene Editing and the Future of Human Health

CRISPR gene editing has revolutionized biomedical research by allowing scientists to precisely manipulate the DNA of human cells. This technology has created unprecedented opportunities to understand the genetic basis of disease—and even to cure certain diseases—while also opening up questions about how to ensure it is used safely and ethically. At this event, NYSCF and the Johns Hopkins Berman Institute of Bioethics hosted an interactive discussion featuring Betsy Myers, PhD, Neville Sanjana, PhD, Susan L. Solomon, JD as well as Johns Hopkins bioethicist Jeffrey Kahn, PhD, MPH to explore the implications of gene editing for research, medicine, and humanity. The panel discussed the immense scientific promise of CRISPR technology and confronted the ethical issues that must be considered as gene editing advances into the clinic.

Read a summary of the event and watch highlights here.

In collaboration with  

Support for this event was provided by